𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of low bone mineral density in a low-income inner-city population

✍ Scribed by Diala El-Maouche; Xiaoqiang Xu; Joseph Cofrancesco Jr; Adrian S Dobs; Todd T Brown


Publisher
American Society for Bone and Mineral Research
Year
2011
Tongue
English
Weight
151 KB
Volume
26
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.

✦ Synopsis


Bone mineral density (BMD) is an important factor linked to bone health. Little is known of the prevalence of low BMD and its associated risk factors in an urban underserved population. Between 2001 and 2004, we recruited 338 subjects who completed drug use and medical history questionnaires, underwent hormonal measurements, and underwent whole-body dual-energy X-ray absorptiometry (DXA) for evaluation of BMD and body composition. Of these, 132 subjects had site-specific DXA (lumbar spine and hip) performed. Osteoporosis was defined as a T-score of –2.5 or less for men 50 years of age and older and postmenopausal women and a Z-score of –2.0 or less in men younger than 50 years of age and premenopausal women at either the lumbar spine, total hip, or femoral neck, according to National Osteoporosis Foundation (NOF) guidelines. The cohort consisted of mostly African-American, middle-aged people with a high prevalence of illicit drug use, 50% HIV^+^, and 39% hepatitis C^+^. Osteoporosis was identified in 22% of subjects (24 men, 5 women), with the majority of cases (90%) attributable to osteoporosis at the lumbar spine. Osteoporosis was more common in men than in women. Lower whole-body BMD among women was associated with multiple risk factors, but only with lower lean mass among men. Osteoporosis was highly prevalent in men, mainly at the spine. The risk factors for bone loss in this population need to be further clarified. Screening men for osteoporosis starting at age 50 might be warranted in this population given the multiple risk factors and the unexpectedly high prevalence of low BMD. Β© 2011 American Society for Bone and Mineral Research.


πŸ“œ SIMILAR VOLUMES


Prevalence and etiology of low bone mine
✍ Sandrine Compeyrot-Lacassagne; Pascal N. Tyrrell; Eshetu Atenafu; Andrea S. Dori πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## Abstract ## Objective Studies of adults with systemic lupus erythematosus (SLE) have frequently demonstrated the presence of decreased bone mineral density (BMD). However, there have been few investigations in pediatric patients to date. This study was undertaken to determine the prevalence of

High prevalence and correlates of low bo
✍ Redonda G. Miller; Jodi B. Segal; Bimal H. Ashar; Sophia Leung; Shamim Ahmed; Sh πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 126 KB πŸ‘ 2 views

## Abstract Sickle cell disease (SCD) is a prevalent genetic disorder in which sickle hemoglobin leads to tissue hypoxia and adverse effects on bone. Published studies suggest that children with SCD often have undiagnosed osteopenia or osteoporosis. Minimal data exist on the prevalence of low bone

Prevalence of and risk factors for low b
✍ Irene E. M. Bultink; Willem F. Lems; Piet J. Kostense; Ben A. C. Dijkmans; Alexa πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 2 views

## Abstract ## Objective To examine the prevalence of and risk factors for low bone mineral density (BMD) and vertebral fractures in patients with systemic lupus erythematosus (SLE). ## Methods We studied 107 SLE patients. Demographic and clinical data were collected, and radiographs of the thor

Rare coding variants in ALPL are associa
✍ Carrie M Nielson; Joseph M Zmuda; Amy S Carlos; Wendy J Wagoner; Emily A Larson; πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 415 KB

## Abstract Alkaline phosphatase (ALP) plays an essential role in the regulation of tissue mineralization, and its activity is highly heritable. Guided by genetic associations discovered in a murine model, we hypothesized a role for rare coding variants in determining serum ALP level and bone miner